{"id":"W2090122150","doi":"10.1016/j.jconrel.2006.09.007","title":"Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Controlled Release","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Chemosensitizer; Doxorubicin; Pharmacology; Chemistry; Cancer cell; Cytotoxic T cell; Multiple drug resistance; Drug delivery; Clonogenic assay; Chemotherapy; Cancer; Apoptosis; Medicine; Biochemistry; In vitro","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001825656,0.000214074,0.0002232043,0.0001243859,0.0001046494,0.0002353552,0.0001533615,0.0002785066,0.000566799],"category_scores_gemma":[0.000110574,0.0001551866,0.0001322068,0.00007728195,0.0001550266,0.0003036793,0.0002152932,0.0002883259,0.0002361248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00029367,"about_ca_system_score_gemma":0.0001462365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003373764,"about_ca_topic_score_gemma":0.0006447131,"domain_scores_codex":[0.9999188,0.00001921505,0.000007167524,0.00002128276,0.00001887028,0.00001466266],"domain_scores_gemma":[0.9999628,0.000007364979,0.00001155954,0.000003846435,0.000004939372,0.000009579241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009689141,0.00001849224,0.00005095492,0.0000277939,0.000003351278,0.00003158831,0.00001169871,0.0001588344,0.9968178,0.00009105874,0.000028211,0.002663282],"study_design_scores_gemma":[0.00003154451,0.0002009889,0.0004073605,0.000002760413,0.00001473297,0.0001346453,0.000005269671,0.001585275,0.9959217,0.00001831388,0.001672961,0.000004332564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890208,0.001354288,0.007776182,0.0001502185,0.00002902387,0.00003528557,0.00005941737,0.00009506639,0.001479913],"genre_scores_gemma":[0.9920594,0.0003838799,0.005443742,0.00003968734,0.00001045474,0.00002665801,0.00004974567,0.00002163989,0.001964815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000566799,"threshold_uncertainty_score":0.002130747,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004367141155643735,"score_gpt":0.229252685957034,"score_spread":0.2248855448013902,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}